Register information Patent

DE file number : 60 2008 045 365.0 (Status: pending/in force, Query started: June 21, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2008 045 365.0
96EP file numberEAKZ08 86 4495.0
86WO file numberWAKZPCT/CA2008/002277
97EP publication numberEPN2222710
87WO publication numberWPN2009079796
54Designation/titleTIREKOMBINANTE RSV-ANTIGENE
51IPC main classICM
(ICMV)
C07K 19/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 39/00 (2006.01), A61K 39/155 (2006.01), A61K 39/295 (2006.01), A61K 9/107 (2006.01), A61P 31/14 (2006.01), A61P 37/04 (2006.01), C07K 14/135 (2006.01), C12N 15/45 (2006.01), C12N 15/62 (2006.01), C07K 14/005 (2006.01), A61K 9/127 (2025.01)
22DE application dateDATDec 23, 2008
96EP application dateEATDec 23, 2008
86WO application dateWATDec 23, 2008
43Date of first publicationOTJul 2, 2009
Date of publication of grantPETJul 27, 2016
71/73Applicant/ownerINHGlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE
72InventorINBAUDOUX, Jean-Pierre, B-1330 Rixensart, BE; BLAIS, Normand, LavalQuébec H6V 3S8, CA; RHEAULT, Patrick, LavalQuébec H7V 3S8, CA; RUELLE, Jean-Louis, B-1330 Rixensart, BE
74RepresentativeVTRVOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE
Address for service VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81634 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
16524 P
Dec 24, 2007
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
56206 P
May 27, 2008
Due dateFT
FG
Dec 31, 2025
Annual fee for the 18th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
81Designated WO countriesWDSAL, RS, BA, MK
Published EP/WO documentsEPWOPNOriginal document: EP000002222710
Searchable text: EP000002222710
Original document: EP000002222710B1
Searchable text: EP000002222710B1
Original document: WO002009079796
Searchable text: WO002009079796
43Date of first publicationEVTJul 2, 2009
Date of the first transfer into DPMAregisterEREGTMay 26, 2011
Date of the (most recent) update in DPMAregisterREGTNov 30, 2024
(Show all update days)(Hide all update days)
  • Nov 30, 2024
    • IPC secondary class(es): changed
    • Due date: changed
  • Jun 8, 2024; Mar 7, 2024; Jan 30, 2024; Nov 29, 2023; Jun 30, 2022; Nov 24, 2021; Nov 17, 2020; Nov 21, 2019; Nov 22, 2018; Oct 25, 2018; Jan 17, 2018; Aug 10, 2017; Jul 6, 2017; Jan 12, 2017; Nov 15, 2016; Aug 18, 2016; Aug 3, 2016; Jul 28, 2016; May 29, 2015; Feb 15, 2013
    • Historical data not available for this/these date(s)
  • May 26, 2011
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO first publication without search report Jul 2, 2009  Details anzeigen
2 Procedure relating to PCT application WO publication Jul 2, 2009  Details anzeigen
3 Procedure relating to EP application EPO 1st publication Sep 1, 2010  Details anzeigen
4 Procedure relating to EP application EPO publication of search report Sep 1, 2010  Details anzeigen
5 Publications Publication of a mention regarding EP 1st publication by DPMA Oct 14, 2010 Oct 14, 2010 Details anzeigen
6 Change of classification Change of IPC main class Dec 18, 2012  Details anzeigen
7 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jul 27, 2016  Details anzeigen
8 Publications Publication by DPMA of mention regarding EP patent grant Sep 8, 2016 Sep 8, 2016 Details anzeigen
9 New applicant/owner details New applicant/owner details Nov 14, 2016 Mar 7, 2024 Details anzeigen
10 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 2, 2017 Aug 10, 2017 Details anzeigen
11 New applicant/owner details New applicant/owner details Jan 29, 2024 Mar 7, 2024 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO first publication without search report
Date of legal/procedural statusVSTTJul 2, 2009
View procedures Procedure relating to PCT application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTJul 2, 2009
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTSep 1, 2010
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of search report
Date of legal/procedural statusVSTTSep 1, 2010
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTOct 14, 2010
Issue numberHN41
YearPJ2010
Publication dateVTOct 14, 2010
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTDec 18, 2012
51IPC main classICM
(ICMV)
C07K 19/00 (2006.01)
51Previous IPC main classICMF
(ICMVF)
C07K 19/00 (2006.01)
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJul 27, 2016
View procedures Publications (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 8, 2016
Issue numberHN36
YearPJ2016
Publication dateVTSep 8, 2016
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 14, 2016
Issue numberHN10
YearPJ2024
Publication dateVTMar 7, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Previous applicant/ownerINHFGlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE, ID Biomedical Corporation of Quebec, Laval, Quebec, CA
Date of update of the procedureREGTMar 7, 2024
View procedures Procedure relating to EP application (No.: 10)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 2, 2017
Issue numberHN32
YearPJ2017
Publication dateVTAug 10, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 11)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 29, 2024
Issue numberHN10
YearPJ2024
Publication dateVTMar 7, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHGlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE
71/73Previous applicant/ownerINHFGlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE, ID Biomedical Corporation of Quebec, Ste Foy, Quebec, CA
Date of update of the procedureREGTMar 7, 2024